Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Fish Attorneys Author Biosimilar Development Article, "An Update On 2020 U.S. Biosimilars Regulation & Litigation"

September 1, 2020

Fish Attorneys Author Biosimilar Development Article, "An Update On 2020 U.S. Biosimilars Regulation & Litigation"

September 1, 2020

Home » Resources » Articles

Fish attorneys John Adkisson, Geoffrey Biegler, Jenny Shmuel, and Philip Chen authored a Biosimilar Development article, “An Update On 2020 U.S. Biosimilars Regulation & Litigation.” In the article, they review the numerous developments in the biosimilars space in 2020, even amidst the global COVID-19 pandemic — and in some cases, because of it. The authors cover regulatory updates, district court litigation, Federal Circuit appeals, inter partes reviews, and other legal developments to watch.

Click here to read the full article on Biosimilar Development, “An Update On 2020 U.S. Biosimilars Regulation & Litigation.”


The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.